Versant Capital Management, Inc Neogenomics Inc Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 699 shares of NEO stock, worth $4,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
699
Previous 2,306
69.69%
Holding current value
$4,249
Previous $22,000
77.27%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
126MCall Options Held
952KPut Options Held
135K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$40.8 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$36.7 Million7.36% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...